108 related articles for article (PubMed ID: 9192981)
1. Low specificity of PGP9.5 expression for detection of micrometastatic neuroblastoma.
Gilbert J; Norris MD; Marshall GM; Haber M
Br J Cancer; 1997; 75(12):1779-81. PubMed ID: 9192981
[TBL] [Abstract][Full Text] [Related]
2. Detection of the PGP9.5 and tyrosine hydroxylase mRNAs for minimal residual neuroblastoma cells in bone marrow and peripheral blood.
Yanagisawa TY; Sasahara Y; Fujie H; Ohashi Y; Minegishi M; Itano M; Morita S; Tsuchiya S; Hayashi Y; Ohi R; Konno T
Tohoku J Exp Med; 1998 Mar; 184(3):229-40. PubMed ID: 9591338
[TBL] [Abstract][Full Text] [Related]
3. [Supersensitive detection of tyrosine hydroxylase mRNA and neuroblastoma cells by reverse transcription and polymerase chain reaction].
Naito H
Hokkaido Igaku Zasshi; 1991 Mar; 66(2):135-41. PubMed ID: 1676393
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of minimal disease in the bone marrow and peripheral blood in neuroblastoma.
Shono K; Tajiri T; Fujii Y; Suita S
J Pediatr Surg; 2000 Oct; 35(10):1415-20. PubMed ID: 11051140
[TBL] [Abstract][Full Text] [Related]
5. Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA.
Miyajima Y; Kato K; Numata S; Kudo K; Horibe K
Cancer; 1995 Jun; 75(11):2757-61. PubMed ID: 7743482
[TBL] [Abstract][Full Text] [Related]
6. Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction.
Naito H; Kuzumaki N; Uchino J; Kobayashi R; Shikano T; Ishikawa Y; Matsumoto S
Eur J Cancer; 1991; 27(6):762-5. PubMed ID: 1676900
[TBL] [Abstract][Full Text] [Related]
7. Real-time analysis of tyrosine hydroxylase gene expression: a sensitive and semiquantitative marker for minimal residual disease detection of neuroblastoma.
Lambooy LH; Gidding CE; van den Heuvel LP; Hulsbergen-van de Kaa CA; Ligtenberg M; Bökkerink JP; De Abreu RA
Clin Cancer Res; 2003 Feb; 9(2):812-9. PubMed ID: 12576454
[TBL] [Abstract][Full Text] [Related]
8. Identification of evolutionary conserved regulatory sequences in the 5' untranscribed region of the neural-specific ubiquitin C-terminal hydrolase (PGP9.5) gene.
Mann DA; Trowern AR; Lavender FL; Whittaker PA; Thompson RJ
J Neurochem; 1996 Jan; 66(1):35-46. PubMed ID: 8522974
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastoma cells in blood and bone marrow.
Träger C; Kogner P; Lindskog M; Ponthan F; Kullman A; Kågedal B
Clin Chem; 2003 Jan; 49(1):104-12. PubMed ID: 12507966
[TBL] [Abstract][Full Text] [Related]
10. PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma.
Stutterheim J; Gerritsen A; Zappeij-Kannegieter L; Kleijn I; Dee R; Hooft L; van Noesel MM; Bierings M; Berthold F; Versteeg R; Caron HN; van der Schoot CE; Tytgat GA
J Clin Oncol; 2008 Nov; 26(33):5443-9. PubMed ID: 18838715
[TBL] [Abstract][Full Text] [Related]
11. Detection of neuroblastoma cells in bone marrow and peripheral blood by different techniques: accuracy and relationship with clinical features of patients.
Corrias MV; Faulkner LB; Pistorio A; Rosanda C; Callea F; Piccolo MS; Scaruffi P; Marchi C; Lacitignola L; Occhino M; Gambini C; Tonini GP; Haupt R; De Bernardi B; Pistoia V; Garaventa A
Clin Cancer Res; 2004 Dec; 10(23):7978-85. PubMed ID: 15585633
[TBL] [Abstract][Full Text] [Related]
12. Pilot study to evaluate MYCN expression as a neuroblastoma cell marker to detect minimal residual disease by RT-PCR.
Wagner LM; Burger RA; Guichard SM; Raimondi SC; Santana VM; Furman WL; Barnette P; Danks MK
J Pediatr Hematol Oncol; 2006 Oct; 28(10):635-41. PubMed ID: 17023822
[TBL] [Abstract][Full Text] [Related]
13. Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA.
Burchill SA; Bradbury FM; Smith B; Lewis IJ; Selby P
Int J Cancer; 1994 Jun; 57(5):671-5. PubMed ID: 7910809
[TBL] [Abstract][Full Text] [Related]
14. Detection of neuroblastoma cells during clinical follow up: advanced flow cytometry and rt-PCR for tyrosine hydroxylase using both conventional and real-time PCR.
Esser R; Glienke W; Bochennek K; Erben S; Quaiser A; Pieper C; Eggert A; Schramm A; Astrahantseff K; Hansmann ML; Schwabe D; Klingebiel T; Koehl U
Klin Padiatr; 2011 Nov; 223(6):326-31. PubMed ID: 22095188
[TBL] [Abstract][Full Text] [Related]
15. Real-time RT-PCR of tyrosine hydroxylase to detect bone marrow involvement in advanced neuroblastoma.
Pession A; Libri V; Sartini R; Conforti R; Magrini E; Bernardi L; Fronza R; Olivotto E; Prete A; Tonelli R; Paolucci G
Oncol Rep; 2003; 10(2):357-62. PubMed ID: 12579272
[TBL] [Abstract][Full Text] [Related]
16. New splicing variants for human Tyrosine Hydroxylase gene with possible implications for the detection of minimal residual disease in patients with neuroblastoma.
Parareda A; Villaescusa JC; Sanchez de Toledo J; Gallego S
Neurosci Lett; 2003 Jan; 336(1):29-32. PubMed ID: 12493595
[TBL] [Abstract][Full Text] [Related]
17. Expression of protein gene product 9.5 and tyrosine hydroxylase in childhood small round cell tumors.
Wang Y; Einhorn P; Triche TJ; Seeger RC; Reynolds CP
Clin Cancer Res; 2000 Feb; 6(2):551-8. PubMed ID: 10690538
[TBL] [Abstract][Full Text] [Related]
18. mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis.
Träger C; Vernby A; Kullman A; Ora I; Kogner P; Kågedal B
Int J Cancer; 2008 Dec; 123(12):2849-55. PubMed ID: 18814238
[TBL] [Abstract][Full Text] [Related]
19. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction.
Gerhard M; Juhl H; Kalthoff H; Schreiber HW; Wagener C; Neumaier M
J Clin Oncol; 1994 Apr; 12(4):725-9. PubMed ID: 7512130
[TBL] [Abstract][Full Text] [Related]
20. Detection of micrometastasis of neuroblastoma to bone marrow and tumor dissemination to hematopoietic autografts using flow cytometry and reverse transcriptase-polymerase chain reaction.
Tsang KS; Li CK; Tsoi WC; Leung Y; Shing MM; Chik KW; Lee V; Ng MH; Yuen P
Cancer; 2003 Jun; 97(11):2887-97. PubMed ID: 12767104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
